All VCS sites will be conducting temperature checks for all patients and visitors at entrances. For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine visits are now available for routine office visits. VCS is keeping updated on current state and local guidance for the Covid vaccine rollout plan. FOR THE LATEST UP TO DATE INFORMATION, ALERTS, VACCINE INFORMATION AND CANCELLATIONS PLEASE CLICK HERE

Archive

Post Archive: Cancer Types

Neelima Denduluri, MD of Virginia Cancer Specialists contributes to ASCO Guideline for Early Breast Cancer Treatment

May 31, 2018
Read More

Dr. Patricia Rodriguez speaks at Tigerlily’s 6th Annual Young Women’s Breast Health Day on the Hill

May 8, 2018
Read More

It's Melanoma Monday, start the season off right with some tips: Detection, Risk Factors and Prevention.

May 7, 2018
Read More

New clinical data for chemotherapy drug administered in metastatic breast cancer co-presented by Dr. Amy Irwin of Virginia Cancer Specialists

March 15, 2018
Read More

Virginia Cancer Specialists and The US Oncology Network Welcome Breast Surgeon, Dr. Hernan Vargas

March 12, 2018
Read More

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

March 6, 2018
Read More

Dr. Robert Reid of Virginia Cancer Specialists presents data on an important Study for Prostate Cancer

February 7, 2018
Read More

Virginia Cancer Specialists enrolls fist patient in Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (AML)

February 7, 2018
Read More

Chemotherapy-induced hair loss treatment available at Virginia Cancer Specialists for Breast Cancer Patients

February 5, 2018
Read More

VCS Enrolls First Patient in Phase 1/2 Clinical Trial of BION-1301-Novel Anti-APRIL Antibody, Treatment of Multiple Myeloma

December 28, 2017
Read More